Under the leadership of the director of KMUH Department of Surgery, Professor Yur-Ren Kuo and with the support of the hospital, the KMUH hand transplant team is the only government-approved hand transplant team in Southern Taiwan. The hand transplant team is built upon multi-specialty integration and collaboration, involving experts in plastic surgery, orthopedics, rehabilitation, nephrology, infectious disease, psychiatry, pathology, anesthesiology, radiology, laboratory testing, etc.
Having undergone countless simulation surgeries and incessant preparation, after a comprehensive evaluation of patient condition, the KMUH hand transplant team completed the first hand allograft transplantation in Taiwan on 11/30/2016, which was also the first near-elbow-level hand allograft transplant in all of East Asia. The recipient is currently faring well with continuous progress and improvement in functional status, as well as total independence in daily activities. Our team was certified by the International Hand and Composite Tissue Allotransplantation Society (IHCTAS). As one of the few medical centers with such a surgical capability in Asia, KMUH boasts many clinical accomplishments and publications of basic science research in renowned international medical journals.
After a complete series of detailed evaluation and exams, a patient of traumatic upper limb injury or congenital upper limb defect is placed on the waitlist. The patient then receives a ten-hour long hand transplant microsurgery (including bone, tendon, neurovascular and skin anastomoses) with a matching donor. Despite gradual decrease in the dosage of the multiple posteropative immunosuppressants prescribed, the immunosuppressants are to be long-term taken throughout the recipient’s lifetime. In addition, the recipient must receive routine blood tests for the serum level of the immunosuppressants and skin biopsies so as to constantly assess for any sign and degree of rejection. In spite of the risk of postoperative complications such as acute or chronic rejection, the KMUH hand transplant team is well-equipped and trained to treat and manage patients' condition.
Arm defect as a result of traumatic injury or congenital disease
- Failure in traditional reconstructive microsurgery or post-reconstruction aesthetic and functional complications
- Between the age of 20 to 55.
- No severe blood-borne infectious diseases, such as HIV, hepatitis B and C carriers.
- No gender restriction.